This is a representational AI image MUMBAI: In April, as US President Donald Trump rattled global markets with his tariff hike proposals for almost all its trading partners, Indians investing in equities listed abroad, especially in the US, showed their smart acumen. They doubled down on investments abroad through the month, mostly buying US stocks…
ICICI Securities has a ‘buy’ rating on Akums Drugs & Pharmaceuticals with a target price of Rs 710. Analysts said that the company is aiming for profitable growth ahead. And the company has been able to maintain its CDMO and overall EBITDA margin at 15.5%/12.0% despite its sub-par revenue growth so far in FY25. Further…
NEW DELHI: Indian equity markets gained ground on Tuesday, with the BSE Sensex rising by 148.80 points, or 0.19%, at 79,644.95, while the Nifty50 advanced 69.05 points, or 0.29%, at 24,210.35. The upward trend followed a cautious start to the week on Monday when global cues, foreign institutional investor (FII) selling, and muted quarterly earnings…
